BioSpace News Archive

Drug Development

PDS Biotech Provides Update on National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based CombinationTemporary administrative suspension of recruitment

PDS Biotechnology Corporation today announced the temporary suspension of recruitment in the National Cancer Institute (NCI)-led Phase 2 clinical trial (NCT04287868) evaluating PDS0101 (Versamune ® -HPV16) in combination with two investigational immune-modulating agents in advanced HPV cancers.

October 21, 2021
·
6 min read
Drug Development

BioCardia Announces First Patient Treated in CardiAMP Cell Therapy Trial for Chronic Myocardial Ischemia

BioCardia®, Inc. today announced the treatment of the first patient in its Phase III pivotal CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial for patients with no option chronic myocardial ischemia with refractory angina.

October 21, 2021
·
8 min read
Drug Development

Frequency Therapeutics Announces First Subject Dosed in FX-322 Phase 2b Acquired Sensorineural Hearing Loss (SNHL) Study and FDA Agreement on Speech Perception as Primary Endpoint

Frequency Therapeutics, Inc. today announced that the first subject has been dosed in a new FX-322 Phase 2b study (FX-322-208) being conducted in a refined population of individuals with SNHL.

October 21, 2021
·
9 min read
Novocure Announces 15 Presentations at the American Society for Radiation Oncology 2021 Annual Meeting

Novocure (NASDAQ: NVCR) today announced 15 presentations on Tumor Treating Fields (TTFields) will be featured at the American Society for Radiation Oncology (ASTRO) 2021 Annual Meeting from Oct. 24 to Oct. 27 in Chicago.

October 21, 2021
·
6 min read
Business

ITOCO Welcomes Maria Teresa Tattersfield Yarza to Its Board of Directors and Carbon Credit Advisory Board

ITOCO INC. (OTC PINK:ITMC) is pleased to welcome Maria Teresa Tattersfield Yarza to its Board of Directors.

October 21, 2021
·
5 min read
Biotech Bay

Gilead Presents Long-Term Switch Data Reinforcing Biktarvy® as a Treatment Option for a Broad Range of People Living With HIV

Gilead Presents Long-Term Switch Data Reinforcing Biktarvy ® as a Treatment Option for a Broad Range of People Living With HIV

October 21, 2021
·
19 min read
Small Pharma Granted Fast-Track Designation From U.K. Regulator for DMT-Assisted Therapy for Major Depressive Disorder

Small Pharma Inc. is pleased to announce that following discussions with the U.K. Medicines and Healthcare products Regulatory Agency (the “ MHRA ”), Small Pharma has been granted an Innovation Passport Designation for SPL026

October 21, 2021
·
6 min read
Business

electroCore to Announce Third Quarter 2021 Financial Results on Thursday, November 4th

electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the third quarter ended September 30, 2021 after the close of the market on Thursday, November 4, 2021.

October 21, 2021
·
1 min read
Business

Adaptimmune to Report Q3 2021 Financial Results and Business Update on Thursday, November 4, 2021

Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will report financial results and provide a business update for the third quarter ended September 30, 2021, before the US markets open on Thursday, November 4, 2021.

October 21, 2021
·
2 min read
Business

Athenex to Provide Corporate and Financial Update for the Third Quarter 2021, on November 5, 2021

Athenex today announced that the Company will provide a corporate and financial update for the third quarter 2021, on Friday, November 5, 2021, before the market opens.

October 21, 2021
·
1 min read